1. Signaling Pathways
  2. Membrane Transporter/Ion Channel
  3. Sodium Channel

Sodium Channel

Sodium channels are integral membrane proteins that form ion channels, conducting sodium ions (Na+) through a cell's plasma membrane. They are classified according to the trigger that opens the channel for such ions, i.e. either a voltage-change (Voltage-gated, voltage-sensitive, or voltage-dependent sodium channel also called VGSCs or Nav channel) or a binding of a substance (a ligand) to the channel (ligand-gated sodium channels). In excitable cells such as neurons, myocytes, and certain types of glia, sodium channels are responsible for the rising phase of action potentials. Voltage-gated Na+ channels can exist in any of three distinct states: deactivated (closed), activated (open), or inactivated (closed). Ligand-gated sodium channels are activated by binding of a ligand instead of a change in membrane potential.

Sodium Channel 相关产品 (107):

Cat. No. Product Name Effect Purity
  • HY-B0407A
    Chlorpromazine hydrochloride Antagonist 99.90%
    Chlorpromazine Hydrochloride 是D25HT2A钾通道钠通道的拮抗剂。 Chlorpromazine Hydrochloride 与 D2 和 5HT2A 结合的 Ki 分别为363 nM和8.3 nM。
  • HY-101840
    EIPA Inhibitor 99.73%
    EIPA (L593754; MH 12-43) 是一种 TRPP3 channel 抑制剂,其 IC50 值为 10.5 μM。EIPA (L593754; MH 12-43) 还抑制 Na+/H+ 交换 (NHE) 和巨噬细胞。
  • HY-B0285A
    Amiloride hydrochloride Inhibitor >98.0%
    Amiloride hydrochloride (MK-870 hydrochloride) 是上皮钠通道 ENaC 抑制剂和尿激酶型纤溶酶原激活物的竞争性抑制剂 (uPA)。
  • HY-B0246
    Carbamazepine Inhibitor 99.35%
    Carbamazepine是压敏钠离子通道阻断剂,IC50为 131 μM。
  • HY-19693
    Cariporide Inhibitor 98.57%
    Cariporide (HOE-642) 是选择性的 Na+/H+ 交换抑制剂。
  • HY-17612
    Evenamide Inhibitor 98.29%
    Evenamide (NW-3509),一种钠通道 (sodium channel) 阻滞剂,在精神病,躁狂症,抑郁和攻击性的各种啮齿动物模型中具有显著功效。
  • HY-128772
    XPC-6444 Inhibitor
    XPC-6444 是一种高效的,亚型选择性的,CNS-渗透性的 NaV1.6 抑制剂 (对 hNaV1.6 的IC50=41 nM)。XPC-6444 也有效阻断了 NaV1.2 (IC50=125 nM)。XPC-6444 具有抗惊厥活性。
  • HY-N6868
    Dimethyl lithospermate B Agonist
    Dimethyl lithospermate B (dmLSB) 是一种选择性的 Na+ 通道激动剂。Dimethyl lithospermate B 减缓钠电流 (INa) 失活,导致动作电位 (AP) 早期内向电流增加。
  • HY-N0603
    20(S)-Ginsenoside Rg3 Inhibitor >98.0%
    20(S)-Ginsenoside Rg3 是红参的主要成分。20(S)-Ginsenoside Rg3 抑制 Na+hKv1.4 通道,IC50 分别为 32.2±4.5 和 32.6±2.2 μM。20(S)-Ginsenoside Rg3 还抑制 NF-κB 活性和 COX-2 表达。
  • HY-B0211
    Riluzole Inhibitor 99.83%
    Riluzole 是一种抗惊厥药物,属于依赖于使用的钠通道阻滞剂家族,它也可以抑制 GABA 摄取,其 IC50 值为 43 μM。
  • HY-B0185A
    Lidocaine hydrochloride Inhibitor 99.95%
    Lidocaine hydrochloride (Lignocaine hydrochloride) 抑制涉及复杂电压和依赖性的钠通道 (sodium channels)。Lidocaine hydrochloride 通过调节 miR-145 表达和进一步抑制 MEK/ERKNF-κB 信号通路来减少胃癌细胞的生长,迁移和侵袭。Lidocaine hydrochloride 是一种酰胺衍生物常用于局部麻醉。Lidocaine hydrochloride 是一种治疗室性心律失常的药物和有效的肿瘤抑制剂。
  • HY-17401
    Ranolazine dihydrochloride Inhibitor 99.92%
    Ranolazine dihydrochloride (CVT 303 dihydrochloride) 是一种抗心绞痛和抗缺血剂,可通过抑制内向钠电流的后期作用 (对 INaIKrIC50 值分别为 6 μM 和 12 μM) 来发挥功效,而不会影响心率或血压。Ranolazine dihydrochloride 还是脂肪酸氧化的部分抑制剂。
  • HY-12883
    PF 05089771 Inhibitor 99.32%
    PF 05089771是出自专利WO/2010/079443 A1中的Nav1.7离子通道阻断剂,IC50值8.6nM。
  • HY-B0185
    Lidocaine Inhibitor 99.52%
    Lidocaine (Lignocaine) 抑制涉及复杂电压和依赖性的钠通道 (sodium channels)。Lidocaine 通过调节 miR-145 表达和进一步抑制 MEK/ERKNF-κB 信号通路来减少胃癌细胞的生长,迁移和侵袭。Lidocaine 是一种酰胺衍生物常用于局部麻醉。Lidocaine 一种治疗室性心律失常的药物和有效的肿瘤抑制剂。
  • HY-B0211A
    Riluzole hydrochloride Inhibitor 99.94%
    Riluzole hydrochloride 是一种抗惊厥药物,属于依赖于使用的钠通道阻滞剂家族,它也可以抑制 GABA 摄取,其 IC50 值为 43 μM。
  • HY-17607
    Cenobamate Inhibitor 99.50%
    Cenobamate,一个钠离子通道 (sodium channel) 阻断剂,能够增强 GABAergic 的传输, 也是一种潜在的、多功能中枢神经系统药物。
  • HY-B0448
    Phenytoin Inhibitor 99.91%
    Phenytoin是非活化的电压门控钠离子通道稳定剂。
  • HY-11079
    A-803467 Inhibitor
    A 803467是Nav1.8钠离子通道阻断剂,IC50为8 nM,比对Nav1.2,1.3,1.5和1.7的抑制性高100倍。
  • HY-B0495
    Lamotrigine Inhibitor 99.94%
    Lamotrigine(BW430C)可抑制5-HT和钠离子通道,可作用于惊厥。
  • HY-15991
    Tenapanor Inhibitor 98.80%
    Tenapanor是钠氢离子 (Na+/H+) 交换NHE3的抑制剂, 抑制人和大鼠NHE3的IC50值分别为5和10 nM。
Isoform Specific Products

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.